CCM
AGN

Credo Capital Management’s Allergan plc AGN Stock Holding History

Credo Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$404K Sell
2,403
-5,638
-70% -$881K 1.74% 9
2013
Q3 		$1.16M Sell
8,041
-12,320
-61% -$1.64M 1.99% 7
2013
Q2 		$2.57M Buy
+20,361
New +$2.31M 1.98% 15

Other funds holding AGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Credo Capital Management's AGN Position: Q4 2013 in Review

Credo Capital Management reduced its Allergan plc (AGN) stake by 70% in Q4 2013, selling an estimated $881K and leaving 2,403 shares worth $404K. The position accounts for 1.74% of the portfolio, ranked #9.

Credo Capital Management first reported a position in AGN in Q2 2013 and has held it in 3 quarters since. The position peaked at $2.57M in Q2 2013. 552 funds tracked by Wall St. Rank hold AGN as of Q4 2013.

  • Credo Capital Management held 2,403 shares of Allergan plc worth $404K as of Q4 2013.
  • Credo Capital Management sold 5,638 Allergan plc shares in Q4 2013, an estimated $881K.
  • Allergan plc made up 1.74% of Credo Capital Management's portfolio in Q4 2013, its #9 holding.
  • Credo Capital Management first reported a position in Allergan plc in Q2 2013 and has held it in 3 quarters since.
  • Credo Capital Management's Allergan plc position peaked at $2.57M in Q2 2013.
  • 552 funds tracked by Wall St. Rank held Allergan plc as of Q4 2013.

Based on Credo Capital Management's 13F filing for Q4 2013, filed 24 Jan 2014.